Drugmakers agree to participate in second round of price negotiations

The manufacturers of each of the 15 drugs selected for Medicare price negotiations have agreed to participate, as reported Fidelity. The process, aimed at lowering the cost of certain drugs deemed to cost the US government the most annually, was implemented under former President Joe Biden's Inflation Reduction Act.